News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Solange Peters will be the keynote speaker for LUNGevity Foundation’s ILCSC24
Photo taken from LUNGevity Foundation/X
Jul 19, 2024, 22:57

Solange Peters will be the keynote speaker for LUNGevity Foundation’s ILCSC24

Amy C. Moore, VP, Global Engagement and Research Partnerships at LUNGevity Foundation, shared a post by LUNGevity Foundation on X, adding:

“I am thrilled that Solange Peters will be our keynote speaker for LUNGevity Foundation’s ILCSC24, happening virtually September 20 – 21. This is a milestone year, marking 20 years since a key discovery with Epidermal Growth Factor Receptor (EGFR) unleashed the era of precision medicine for lung cancer. Don’t miss it!”

Quoting LUNGevity Foundation’s post:

“We are excited to announce the Keynote Speaker for the International Lung Cancer Survivorship Conference is thoracic oncologist and ‘Giants of Cancer Care’ awardee, Solange Peters.”

Additional information
Source: Amy C. Moore/X and LUNGevity Foundation/X

Amy C. Moore cancer Epidermal Growth Factor Receptor (EGFR) ILCSC24 International Lung Cancer Survivorship Conference Lung cancer LUNGevity Foundation OncoDaily Oncology Precision Medicine Solange Peters
Special Coverage
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research
Blog
Jan 20, 2025, 02:54
Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach
Science
Jan 20, 2025, 02:44
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Science
Jan 20, 2025, 02:16
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Blog
Jan 20, 2025, 02:14
Akriti Jain: Grateful to present at Cleveland Clinic ASH review
Career
Jan 19, 2025, 23:12
Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era